What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Alzheimer's disease
- Disease
Reisa A. Sperling spends much of his time researching Alzheimer's disease, Neuroscience, Dementia, Disease and Cognition.
His Alzheimer's disease research is multidisciplinary, incorporating elements of Biomarker, Neuroimaging and Cognitive decline.
His Dementia research is multidisciplinary, incorporating perspectives in Gerontology, Predictive value of tests, Age of onset, PSEN1 and Amyloid.
His studies in Disease integrate themes in fields like Psychiatry, Clinical trial, Bioinformatics and Intensive care medicine.
Reisa A. Sperling focuses mostly in the field of Cognition, narrowing it down to topics relating to Cohort study and, in certain cases, Executive dysfunction and Activities of daily living.
His research integrates issues of Placebo and Oncology in his study of Internal medicine.
His most cited work include:
- Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease (4114 citations)
- NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease (2145 citations)
- Clinical and Biomarker Changes in Dominantly Inherited Alzheimer’s Disease (2062 citations)
What are the main themes of his work throughout his whole career to date?
His main research concerns Disease, Neuroscience, Internal medicine, Alzheimer's disease and Dementia.
His study focuses on the intersection of Disease and fields such as Cognition with connections in the field of Clinical psychology, Audiology and Developmental psychology.
As a member of one scientific family, Reisa A. Sperling mostly works in the field of Neuroscience, focusing on Amyloid and, on occasion, Positron emission tomography.
His biological study spans a wide range of topics, including Endocrinology and Oncology.
His Alzheimer's disease research includes themes of Magnetic resonance imaging and Neuroimaging.
His research in Dementia focuses on subjects like Gerontology, which are connected to Activities of daily living.
He most often published in these fields:
- Disease (43.50%)
- Neuroscience (38.92%)
- Internal medicine (36.00%)
What were the highlights of his more recent work (between 2018-2021)?
- Disease (43.50%)
- Internal medicine (36.00%)
- Cognitive decline (28.62%)
In recent papers he was focusing on the following fields of study:
The scientist’s investigation covers issues in Disease, Internal medicine, Cognitive decline, Cognition and Amyloid.
His work in Disease addresses subjects such as Neurology, which are connected to disciplines such as Audiology.
His Internal medicine research focuses on subjects like Oncology, which are linked to Biomarker and Positron emission tomography.
His Cognitive decline research entails a greater understanding of Dementia.
Anxiety is closely connected to Depression in his research, which is encompassed under the umbrella topic of Cognition.
His Amyloid study also includes fields such as
- Neuroscience which is related to area like Tauopathy,
- Tau pathology that intertwine with fields like Locus coeruleus.
Between 2018 and 2021, his most popular works were:
- Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report. (300 citations)
- Association of Amyloid and Tau With Cognition in Preclinical Alzheimer Disease : A Longitudinal Study (148 citations)
- Association of Amyloid and Tau With Cognition in Preclinical Alzheimer Disease : A Longitudinal Study (148 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Disease
- Alzheimer's disease
His scientific interests lie mostly in Internal medicine, Alzheimer's disease, Dementia, Cognitive decline and Cognition.
His study in the fields of Apolipoprotein E, Family history and Amyloid deposition under the domain of Internal medicine overlaps with other disciplines such as Preliminary analysis.
Alzheimer's disease is a subfield of Pathology that he studies.
His Dementia study incorporates themes from Temporal lobe, Asymptomatic, Entorhinal cortex, Pediatrics and Tauopathy.
His Cognitive decline research includes elements of Alzheimer's Disease Neuroimaging Initiative, Aging brain and Pittsburgh compound B, Amyloid.
His Cognition study integrates concerns from other disciplines, such as Disease, Cohort and Depression.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
